Bone marrow–mesenchymal stromal cell infusion in patients with chronic kidney disease: A safety study with 18 months of follow-up

Autor: Makhlough, Atieh *, Shekarchian, Soroosh *, Moghadasali, Reza, Einollahi, Behzad, Dastgheib, Mona, Janbabaee, Ghasem, Hosseini, Seyedeh Esmat, Falah, Nasrin, Abbasi, Fateme, Baharvand, Hossein, Aghdami, Nasser *
Zdroj: In Cytotherapy May 2018 20(5):660-669
Databáze: ScienceDirect